The DOI matches its Crossref record.
Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ametamey, S. M., Honer, M., & Schubiger, P. A. (2008) · Chemical Reviews · doi:10.1021/cr0782426 · Cited by 1,271
Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder
Saxena, S., & Rauch, S. L. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70181-7 · Cited by 840
Neuroimaging and frontal–subcortical circuitry in obsessive–compulsive disorder
Saxena, S., Brody, A. L., Schwartz, J. M., & Baxter, L. R. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297870 · Cited by 831
Prefrontal Dopamine D1Receptors and Working Memory in Schizophrenia
Abi-Dargham, A., Mawlawi, O., Lombardo, I., Gil, R., Martinez, D., Huang, Y., Hwang, D.-R., Keilp, J., Kochan, L., Van Heertum, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03708.2002 · Cited by 724
“these receptors is much lower than in the striatum (Hall et al., 1994).”
BackgroundAmphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706
Barth, C., Villringer, A., & Sacher, J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00037 · Cited by 711
Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET
Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Sassa, T., Sudo, Y., Matsushima, E., et al. (1997) · Nature · doi:10.1038/385634a0 · Cited by 710
Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.237 · Cited by 697
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612
Leyton, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00366-4 · Cited by 476
Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum
Martinez, D., Gil, R., Slifstein, M., Hwang, D.-R., Huang, Y., Perez, A., Kegeles, L., Talbot, P., Evans, S., Krystal, J., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.044 · Cited by 445
Dopaminergic reward system: a short integrative review
Arias-Carrión, O., Stamelou, M., Murillo-Rodríguez, E., Menéndez-González, M., & Pöppel, E. (2010) · International Archives of Medicine · doi:10.1186/1755-7682-3-24 · Cited by 416
Dopaminergic mechanisms of individual differences in human effort-based decision-making
Treadway, M. T., Buckholtz, J. W., Cowan, R. L., Woodward, N. D., Li, R., Ansari, M. S., Baldwin, R. M., Schwartzman, A. N., Kessler, R. M., & Zald, D. H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6459-11.2012 · Cited by 385
Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain.
Varnäs, K., Halldin, C., & Hall, H. (2004) · Human Brain Mapping · doi:10.1002/hbm.20035 · Cited by 332
Self-citationPiggott, M. A., Marshall, E. F., Thomas, N., Lloyd, S., Court, J. A., Jaros, E., Burn, D., Johnson, M., Perry, R. H., McKeith, I. G., et al. (1999) · Brain · doi:10.1093/brain/122.8.1449 · Cited by 330
Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia
Sarpal, D. K., Robinson, D. G., Lencz, T., Argyelan, M., Ikuta, T., Karlsgodt, K., Gallego, J. A., Kane, J. M., Szeszko, P. R., & Malhotra, A. K. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1734 · Cited by 327
D1- Versus D2-Receptor Modulation of Visuospatial Working Memory in Humans
Müller, U., von Cramon, D. Y., & Pollmann, S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02720.1998 · Cited by 325
Wang, Y., Tong, Q., Ma, S.-R., Zhao, Z.-X., Pan, L.-B., Cong, L., Han, P., Peng, R., Yu, H., Lin, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00456-5 · Cited by 319
Martinez, D., Broft, A., Foltin, R. W., Slifstein, M., Hwang, D.-R., Huang, Y., Perez, A., Frankel, W. G., Cooper, T., Kleber, H. D., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300420 · Cited by 306
“…volume (VT, ml g 1) was defined as the ratio of the ligand concentration in a region (CT, mCi g 1) to the concentration of unmetabolized ligand in venous plasma (CP, mCi ml 1) at equilibrium, VT ¼ CT CP ð1Þ The concentration of D2 receptors is negligible in the cerebellum (Hall et al, 1994).”
BackgroundNeurobehavioral evidence for changes in dopamine system activity during adolescence
Wahlstrom, D., White, T., & Luciana, M. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.007 · Cited by 277
“D1 density appears to be higher compared to D2 density in limbic and cortical regions (Hall et al., 1994), although the densities of both receptor types are greater in striatal and limbic regions as compared to the cortex (Meador-Woodruff et al.”
BackgroundHall, H., Lundkvist, C., Halldin, C., Farde, L., Pike, V. W., McCarron, J. A., Fletcher, A., Cliffe, I. A., Barf, T., Wikström, H., et al. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01131-6 · Cited by 280
Self-citationPrefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia
Abi-Dargham, A., & Moore, H. (2003) · The Neuroscientist · doi:10.1177/1073858403252674 · Cited by 277
Mukherjee, J., Christian, B. T., Dunigan, K. A., Shi, B., Narayanan, T. K., Satter, M., & Mantil, J. (2002) · Synapse · doi:10.1002/syn.10128 · Cited by 270
Striatal dopamine D1 and D2 receptors in burning mouth syndrome
Hagelberg, N., Forssell, H., Rinne, J. O., Scheinin, H., Taiminen, T., Aalto, S., Luutonen, S., Någren, K., & Jääskeläinen, S. (2003) · Pain · doi:10.1016/s0304-3959(02)00323-8 · Cited by 264
D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain
Hurd, Y. L., Suzuki, M., & Sedvall, G. C. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00122-3 · Cited by 262
Self-citationUrban, N. B. L., Kegeles, L. S., Slifstein, M., Xu, X., Martinez, D., Sakr, E., Castillo, F., Moadel, T., O'Malley, S. S., Krystal, J. H., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.005 · Cited by 223
Volkow, N. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00104-9 · Cited by 217
Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging
Kaller, S., Rullmann, M., Patt, M., Becker, G.-A., Luthardt, J., Girbardt, J., Meyer, P. M., Werner, P., Barthel, H., Bresch, A., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3645-0 · Cited by 152
Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135
Postnatal alterations in dopaminergic markers in the human prefrontal cortex
Weickert, C. S., Webster, M. J., Gondipalli, P., Rothmond, D., Fatula, R. J., Herman, M. M., Kleinman, J. E., & Akil, M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.009 · Cited by 126
Shaw, P., De Rossi, P., Watson, B., Wharton, A., Greenstein, D., Raznahan, A., Sharp, W., Lerch, J. P., & Chakravarty, M. M. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.05.003 · Cited by 126
Estimating Dopamine D2 Receptor Occupancy for Doses of 8 Antipsychotics: A Meta-Analysis
Lako, I. M., van den Heuvel, E. R., Knegtering, H., Bruggeman, R., & Taxis, K. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182983ffa · Cited by 125
“Inclusion criteria were as follows: (1) investigation of D2 receptor occupancy in striatal areas (including the putamen and basal ganglia), as striatal areas are known to be richer of dopamine receptors than extrastriatal areas.(17,18) (2) Study populations consisting of patients with a diagnosis of schizophrenia or p…”
BackgroundPET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum
Drevets, W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00079-2 · Cited by 122
“Since non-basal ganglia tissues have DA D2/D3 densities , 10% of that of the striatum, they were assumed to reflect non-specifically bound tracer (Hall et al. 1994).”
BackgroundMethodResultInfluentialJucaite, A., Forssberg, H., Karlsson, P., Halldin, C., & Farde, L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.034 · Cited by 67
Self-citationRao, N., Northoff, G., Tagore, A., Rusjan, P., Kenk, M., Wilson, A., Houle, S., Strafella, A., Remington, G., & Mizrahi, R. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby076 · Cited by 67
Albaugh, M. D., Orr, C., Chaarani, B., Althoff, R. R., Allgaier, N., D’Alberto, N., Hudson, K., Mackey, S., Spechler, P. A., Banaschewski, T., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.01.003 · Cited by 63
“It is possible that these findings can be explained, in part, by the differential distribution of D1 and D2 receptors in the human brain (45).”
BackgroundDifferential dopaminergic modulation of executive control in healthy subjects
Roesch-Ely, D., Scheffel, H., Weiland, S., Schwaninger, M., Hundemer, H.-P., Kolter, T., & Weisbrod, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2027-z · Cited by 56
“Regarding the selectivity of dopamine agonists on cognition, at the neuroanatomical level it is known that there is a predominance of D1 subtypes in the mesocortical pathway (which projects from the basal ganglia to the PFC) in comparison with the D2-subtype receptor (Hall et al. 1994; Lidow et al. 1991).”
Olver, J. S., O'Keefe, G., Jones, G. R., Burrows, G. D., Tochon-Danguy, H. J., Ackermann, U., Scott, A. M., & Norman, T. R. (2010) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2010.04.004 · Cited by 42
Minuzzi, L., & Cumming, P. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.01.010 · Cited by 15
Metadata
- Authors
- Hall, H., Sedvall, G., Magnusson, O., Kopp, J., Halldin, C., & Farde, L.
- Venue
- Neuropsychopharmacology
- Published
- 1994-12
- Volume
- 11
- Issue
- 4
- Pages
- 245-256
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1979792701
- Cited by
- 419
- References
- 0
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.